Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-29 Purchase | 2023-03-30 5:55 pm | ATAI Life Sciences N.V. | ATAI | Brand Florian See Remarks | 70,000 | $1.4794 | $103,558 | 72,333 (Indirect Direct) | View |
| 2023-03-29 Purchase | 2023-03-29 4:05 pm | ATAI Life Sciences N.V. | ATAI | Apeiron Investment Group Ltd. Angermayer Christian 10% Owner | 1,214,297 | $1.318 | $1,600,443 | 33,885,999 (Indirect) | View |
| 2022-04-20 Purchase | 2022-05-03 4:16 pm | ATAI Life Sciences N.V. | ATAI | Apeiron Investment Group Ltd. Angermayer Christian 10% Owner | 136,391 | $5.0191 | $684,553 | 1,614,911 (Indirect) | View |
| 2022-04-28 Purchase | 2022-05-02 4:15 pm | ATAI Life Sciences N.V. | ATAI | Apeiron Investment Group Ltd. Angermayer Christian 10% Owner | 56,600 | $4.461 | $252,490 | 1,799,302 (Indirect) | View |
| 2022-04-26 Purchase | 2022-04-28 4:26 pm | ATAI Life Sciences N.V. | ATAI | Apeiron Investment Group Ltd. Angermayer Christian 10% Owner | 66,010 | $4.6745 | $308,567 | 1,742,702 (Indirect) | View |
| 2022-04-22 Purchase | 2022-04-26 4:15 pm | ATAI Life Sciences N.V. | ATAI | Apeiron Investment Group Ltd. Angermayer Christian 10% Owner | 61,781 | $4.8203 | $297,805 | 1,676,692 (Indirect) | View |
| 2022-04-18 Purchase | 2022-04-20 4:30 pm | ATAI Life Sciences N.V. | ATAI | Apeiron Investment Group Ltd. Angermayer Christian 10% Owner | 119,637 | $5.1188 | $612,395 | 1,478,520 (Indirect) | View |
| 2022-04-14 Purchase | 2022-04-18 4:15 pm | ATAI Life Sciences N.V. | ATAI | Apeiron Investment Group Ltd. Angermayer Christian 10% Owner | 4,967 | $5.19 | $25,779 | 1,358,883 (Indirect) | View |
| 2022-04-12 Purchase | 2022-04-14 4:15 pm | ATAI Life Sciences N.V. | ATAI | Apeiron Investment Group Ltd. Angermayer Christian 10% Owner | 55,197 | $4.8836 | $269,560 | 1,353,916 (Indirect) | View |
| 2022-04-08 Purchase | 2022-04-12 4:30 pm | ATAI Life Sciences N.V. | ATAI | Apeiron Investment Group Ltd. Angermayer Christian 10% Owner | 111,615 | $4.8219 | $538,194 | 1,298,719 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-05-23 Option Award | 2023-05-25 4:17 pm | N/A 2033-05-23 | ATAI Life Sciences N.V. | ATAI | Smiley Andrea Heslin Director | 64,000 | $0 | 64,000 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 4:16 pm | N/A 2033-05-23 | ATAI Life Sciences N.V. | ATAI | Camm Jason Director | 64,000 | $0 | 64,000 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 4:16 pm | N/A 2033-05-23 | ATAI Life Sciences N.V. | ATAI | Angermayer Christian Director 10% Owner | 64,000 | $0 | 64,000 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 4:15 pm | N/A 2033-05-23 | ATAI Life Sciences N.V. | ATAI | Kalali Amir H Director | 64,000 | $0 | 64,000 (Direct) | View |
Ownership | 2023-05-19 5:36 pm | N/A N/A | ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Accounting Officer | 0 | $0 | 1,414,188 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-16 8:27 pm | N/A 2033-03-14 | ATAI Life Sciences N.V. | ATAI | Rao Srinivas See Remarks | 950,000 | $0 | 950,000 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-16 8:24 pm | N/A 2033-03-14 | ATAI Life Sciences N.V. | ATAI | Brand Florian See Remarks | 2,300,000 | $0 | 2,300,000 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-16 8:23 pm | N/A 2033-03-14 | ATAI Life Sciences N.V. | ATAI | Bardin Stephen Chief Financial Officer | 950,000 | $0 | 950,000 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-16 8:22 pm | N/A 2033-03-14 | ATAI Life Sciences N.V. | ATAI | Gutierrez-Esteinou Rolando Chief Medical Officer | 700,000 | $0 | 700,000 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-16 8:20 pm | N/A 2033-03-14 | ATAI Life Sciences N.V. | ATAI | Kirpekar Sahil Chief Business Officer | 475,000 | $0 | 475,000 (Direct) | View |
| 2022-12-01 Option Award | 2022-12-02 4:20 pm | N/A 2032-12-01 | ATAI Life Sciences N.V. | ATAI | Kirpekar Sahil Chief Business Officer | 750,000 | $0 | 750,000 (Direct) | View |
Ownership | 2022-08-17 06:05 am | N/A 2032-07-01 | ATAI Life Sciences N.V. | ATAI | Bardin Stephen Chief Financial Officer | 0 | $0 | 1,000,000 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-27 5:55 pm | N/A 2032-05-25 | ATAI Life Sciences N.V. | ATAI | Smiley Andrea Heslin Director | 64,000 | $0 | 64,000 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-27 5:50 pm | N/A 2032-05-25 | ATAI Life Sciences N.V. | ATAI | Kalali Amir H Director | 64,000 | $0 | 64,000 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-27 5:49 pm | N/A 2032-05-25 | ATAI Life Sciences N.V. | ATAI | Auerbach Michael Director | 64,000 | $0 | 64,000 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-27 5:49 pm | N/A 2032-05-25 | ATAI Life Sciences N.V. | ATAI | Angermayer Christian Director 10% Owner | 64,000 | $0 | 64,000 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-27 5:46 pm | N/A 2032-05-25 | ATAI Life Sciences N.V. | ATAI | JOHNSON SABRINA MARTUCCI Director | 64,000 | $0 | 64,000 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-27 5:39 pm | N/A 2032-05-25 | ATAI Life Sciences N.V. | ATAI | de Rosnay Alexis Director | 64,000 | $0 | 64,000 (Direct) | View |
| 2022-03-02 Option Award | 2022-03-04 4:04 pm | N/A 2032-03-01 | ATAI Life Sciences N.V. | ATAI | Gutierrez-Esteinou Rolando Chief Medical Officer | 206,950 | $0 | 206,950 (Direct) | View |
| 2022-03-02 Option Award | 2022-03-04 3:56 pm | N/A 2025-08-20 | ATAI Life Sciences N.V. | ATAI | Rao Srinivas See Remarks | 2,666,648 | $0 | 2,666,648 (Direct) | View |
| 2022-03-02 Option Award | 2022-03-04 3:56 pm | N/A 2032-03-01 | ATAI Life Sciences N.V. | ATAI | WEAVER GREGORY L Chief Financial Officer | 228,000 | $0 | 228,000 (Direct) | View |
| 2022-03-02 Option Award | 2022-03-04 3:53 pm | N/A 2032-03-01 | ATAI Life Sciences N.V. | ATAI | Brand Florian See Remarks | 649,050 | $0 | 649,050 (Direct) | View |
| 2021-12-24 Option Award(A) | 2022-03-04 3:49 pm | N/A N/A | ATAI Life Sciences N.V. | ATAI | Gutierrez-Esteinou Rolando Chief Medical Officer | 0 | $0 | 0 (Direct) | View |
Ownership | 2022-02-28 9:00 pm | N/A N/A | COMPASS Pathways plc | CMPS | ATAI Life Sciences N.V. ATAI Life Sciences AG 10% Owner | 0 | $0 | 9,565,774 (Indirect) | View |
| 2022-01-14 Other | 2022-01-19 4:30 pm | N/A N/A | ATAI Life Sciences N.V. | ATAI | Auerbach Michael Director | 5,559,808 | $0 | 6,084,116 (Indirect) | View |
| 2021-12-24 Option Award | 2021-12-28 5:42 pm | N/A 2031-12-23 | ATAI Life Sciences N.V. | ATAI | Gutierrez-Esteinou Rolando Chief Medical Officer | 325,000 | $0 | 325,000 (Direct) | View |
| 2021-09-10 Option Award | 2021-09-13 4:31 pm | N/A 2031-09-10 | ATAI Life Sciences N.V. | ATAI | Kalali Amir H Director | 128,000 | $0 | 128,000 (Direct) | View |